ASCO is establishing the Quality Training Program to teach oncology providers to lead successful quality improvement activities in their practice settings. This six-month program begins in the fall and will offer comprehensive education and training for 15 interdisciplinary oncology teams.

[Read the rest of this article...]

The American Society of Clinical Oncology, the American Association for Cancer Research, the Association of American Cancer Institutes, and Friends of Cancer Research recognized Sen. Richard Shelby (R-Ala.) and Rep. Rosa DeLauro (D-Conn.) for their outstanding commitment to cancer research and leadership in funding for biomedical science.

[Read the rest of this article...]

On May 15, 2013, the U.S. Food and Drug Administration approved radium Ra 223 dichloride (Xofigo Injection, Bayer HealthCare Pharmaceuticals Inc.) for...

[Read the rest of this article...]

On May 14, 2013, the U. S. Food and Drug Administration approved erlotinib (Tarceva®, Astellas Pharma Inc.) for the first-line treatment of metast...

[Read the rest of this article...]

ASCO, along with the American Association for Cancer Research, the Association of American Cancer Institutes and Friends of Cancer Research, is holding an advocacy day on Capitol Hill this week to advocate for sustained funding for the National Institutes of Health and the Food and Drug Administration.

[Read the rest of this article...]

A new ASCO survey of U.S. oncology practices shows the automatic two percent budget cut to Medicare chemotherapy drug reimbursement under sequestration is already having a significant impact on care for people with cancer just one month after the federal funding reduction went into effect.

[Read the rest of this article...]

In letters to bill sponsors, Representatives Phil Roe, MD (R-Tenn.) Allyson Schwartz (D-Pa.) and Senator John Cornyn (R-Tex.), ASCO is supporting the “Protecting Seniors Access to Medicare Act,” which would repeal the Independent Payment Advisory Board (IPAB). The IPAB, created by the Affordable Care Act, is a 15-member panel charged with the authority to make targeted cuts to Medicare, including payments to physicians, if the program’s overall costs rise faster than a certain rate.

[Read the rest of this article...]

Practices who have received a denial for add-on code 96361 will have the opportunity to appeal the denial or resubmit their claims after July 1 due to revisions by the agency.

[Read the rest of this article...]